Skip to main content

Ethic Inc.

SEC CIK
0001780570
Latest filing
Jul 29, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Ethic Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
365,253
Value
$5.85M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by Ethic Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026365,253$5.85M0.1%+30,417+9.1%AddedHolders
Q1 2026334,836$6.20M0.1%+30,181+9.9%AddedHolders
Q4 2025304,655$4.75M0.1%−6,096−2.0%ReducedHolders
Q3 2025310,751$4.55M0.1%+43,295+16.2%AddedHolders
Q2 2025267,456$4.04M0.1%+47,921+21.8%AddedHolders
Q1 2025219,535$3.27M0.1%−106,772−32.7%ReducedHolders
Q4 2024326,307$4.32M0.1%−113,512−25.8%ReducedHolders
Q3 2024439,819$6.11M0.2%−16,055−3.5%ReducedHolders
Q2 2024455,874$5.90M0.1%+16,055+3.7%AddedHolders
Q1 2024439,819$6.11M0.2%+74,488+20.4%AddedHolders
Q4 2023365,331$5.21M0.2%−96,516−20.9%ReducedHolders
Q3 2023461,847$7.14M0.3%+58,945+14.6%AddedHolders
Q2 2023402,902$6.33M0.2%+47,123+13.2%AddedHolders
Q1 2023355,779$5.86M0.2%+60,971+20.7%AddedHolders
Q4 2022294,808$4.60M0.2%+155,562+111.7%AddedHolders
Q3 2022139,246$1.81M0.1%−19,617−12.3%ReducedHolders
Q2 2022158,863$2.23M0.2%−87,765−35.6%ReducedHolders
Q1 2022246,628$3.53M0.2%+106,763+76.3%AddedHolders
Q4 2021139,865$1.91M0.1%+50,384+56.3%AddedHolders
Q3 202189,481$1.47M0.2%+21,748+32.1%AddedHolders
Q2 202167,733$1.14M0.1%+10,438+18.2%AddedHolders
Q1 202157,295$1.05M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.